Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Propanc Biopharma Inc (PPCB)

Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 67
  • Shares Outstanding, K 167,979
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,660 K
  • 60-Month Beta 1.99
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PPCB with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings $-0.01 on 05/15/24
  • Next Earnings Date 09/26/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0003 +33.33%
on 09/13/24
0.0006 -33.33%
on 08/28/24
-0.0001 (-20.00%)
since 08/16/24
3-Month
0.0003 +33.33%
on 09/13/24
0.0018 -77.78%
on 06/20/24
-0.0009 (-69.23%)
since 06/18/24
52-Week
0.0003 +33.33%
on 09/13/24
0.0320 -98.75%
on 09/19/23
-0.0291 (-98.64%)
since 09/18/23

Most Recent Stories

More News
Propanc Biopharma Announces That PRP Suppresses TGF-β Pathway & Tumor Microenvironment in Pancreatic Cancer

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer,...

OTC.VN : 0.320 (unch)
PPCB : 0.0004 (unch)
Propanc Biopharma Confirms PRP Exerts Significant Effects Against Chemoresistant Pancreatic Tumor Cells

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer,...

OTC.VN : 0.320 (unch)
PPCB : 0.0004 (unch)
Propanc Biopharma’s Joint Researcher Presents at the 43rd Meeting of the European Organization of Research & Treatment of Cancer (EORTC)

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer,...

OTC.VN : 0.320 (unch)
PPCB : 0.0004 (unch)
Propanc Biopharma’s Joint Researcher Receives Award at Doctoral Conference at the University of Jaén

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer,...

OTC.VN : 0.320 (unch)
PPCB : 0.0004 (unch)
Propanc Biopharma Concludes PRP Could Become an Effective Chemosensitizer Agent Against Pancreatic Cancer

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer,...

OTC.VN : 0.320 (unch)
PPCB : 0.0004 (unch)
Propanc Biopharma’s CSO Predicts PRP Could Enhance Therapeutic Effects of Immune Checkpoint Therapy for Pancreatic Cancer

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer,...

OTC.VN : 0.320 (unch)
PPCB : 0.0004 (unch)
Propanc Biopharma’s CEO to Present at Sidoti & Company Micro-Cap Virtual Investor Conference

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer,...

OTC.VN : 0.320 (unch)
PPCB : 0.0004 (unch)
Propanc Biopharma’s CEO to Attend 43rd Meeting of the European Organization of Research & Treatment of Cancer (EORTC), Dec 15 - 17

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer,...

OTC.VN : 0.320 (unch)
PPCB : 0.0004 (unch)
Propanc Biopharma Targets Pancreatic & Ovarian Cancers for PRP Clinical Studies with Combined Markets to Reach Over $14.3 Billion by 2027

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer,...

OTC.VN : 0.320 (unch)
PPCB : 0.0004 (unch)
Propanc Biopharma Provides Shareholder Update

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer,...

OTC.VN : 0.320 (unch)
PPCB : 0.0004 (unch)

Business Summary

Propanc Biopharma, Inc. is a healthcare company. It focuses on the development of cancer treatments for pancreatic, ovarian and colorectal cancer primarily in Australia. The Company's products include PRP and PRP-DCM. Propanc Biopharma, Inc., formerly known as Propanc Health Group Corporation, is based...

See More

Key Turning Points

3rd Resistance Point 0.0004
2nd Resistance Point 0.0004
1st Resistance Point 0.0004
Last Price 0.0004
1st Support Level 0.0004
2nd Support Level 0.0004
3rd Support Level 0.0004

See More

52-Week High 0.0320
Fibonacci 61.8% 0.0199
Fibonacci 50% 0.0162
Fibonacci 38.2% 0.0124
Last Price 0.0004
52-Week Low 0.0003

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar